Joanne Mortimer, M.D., F.A.C.P. is the Vice Chair for Medical Oncology at the City of Hope. She is also the Director of the Women’s Cancers Program and the Associate Director for Affiliate Programs. Dr. Mortimer has participated in clinical trials in breast cancer for over 25 years. Her research has focused on assessing the effects of systemic therapies on cancer and normal tissues. Many of these trials have utilized functional imaging and other biomarkers. She is studying the impact of toxicity on breast cancer disease outcome and quality of life. She and her colleagues reported a favorable outcome for women treated with tamoxifen who experience hot flashes.
Dr. Mortimer received her medical degree from the Stritch College of Medicine at Loyola University and completed her internal medicine residency and an oncology fellowship at the Cleveland Clinic Foundation. Previously, Dr. Mortimer was the Deputy Director of Medical Oncology at the Moores Cancer Center at the University of California, San Diego, medical director of the Sentara Cancer Institute; head of hematology and medical oncology and professor of internal medicine at the Eastern Virginia Medical School; director of clinical oncology and professor of medicine at the Washington University School of Medicine in St. Louis, Mo.; associate of clinical research at the Fred Hutchison Cancer Center in Seattle and assistant professor at the University of Washington’s School of Medicine.
Dr. Mortimer is currently an advisor for the Oncologic Drug Advisory Committee of the U.S. Food and Drug Administration
Abstracts this author is presenting: